"Narcotic Antagonists" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Agents inhibiting the effect of narcotics on the central nervous system.
| Descriptor ID |
D009292
|
| MeSH Number(s) |
D27.505.696.543 D27.505.696.663.850.512 D27.505.954.427.550
|
| Concept/Terms |
Narcotic Antagonists- Narcotic Antagonists
- Antagonists, Narcotic
- Opioid Receptor Antagonists
- Antagonists, Opioid Receptor
- Receptor Antagonists, Opioid
- Opioid Antagonists
- Antagonists, Opioid
|
Below are MeSH descriptors whose meaning is more general than "Narcotic Antagonists".
Below are MeSH descriptors whose meaning is more specific than "Narcotic Antagonists".
This graph shows the total number of publications written about "Narcotic Antagonists" by people in this website by year, and whether "Narcotic Antagonists" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 0 | 1 |
| 1996 | 2 | 1 | 3 |
| 1997 | 4 | 0 | 4 |
| 1998 | 1 | 0 | 1 |
| 1999 | 6 | 0 | 6 |
| 2000 | 5 | 1 | 6 |
| 2001 | 3 | 1 | 4 |
| 2002 | 5 | 3 | 8 |
| 2003 | 0 | 1 | 1 |
| 2004 | 4 | 1 | 5 |
| 2005 | 1 | 1 | 2 |
| 2006 | 6 | 1 | 7 |
| 2007 | 4 | 3 | 7 |
| 2008 | 5 | 1 | 6 |
| 2009 | 5 | 2 | 7 |
| 2010 | 3 | 1 | 4 |
| 2011 | 1 | 1 | 2 |
| 2012 | 1 | 2 | 3 |
| 2013 | 7 | 0 | 7 |
| 2014 | 6 | 1 | 7 |
| 2015 | 2 | 0 | 2 |
| 2016 | 1 | 0 | 1 |
| 2017 | 2 | 2 | 4 |
| 2018 | 1 | 3 | 4 |
| 2019 | 3 | 3 | 6 |
| 2020 | 1 | 1 | 2 |
| 2021 | 1 | 2 | 3 |
| 2022 | 0 | 1 | 1 |
| 2024 | 3 | 0 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Narcotic Antagonists" by people in Profiles.
-
Agent-Based Model of Combined Community- and Jail-Based Take-Home Naloxone Distribution. JAMA Netw Open. 2024 Dec 02; 7(12):e2448732.
-
Accessibility of Naloxone in Pharmacies Registered Under the Illinois Standing Order. West J Emerg Med. 2024 Jul; 25(4):457-464.
-
Availability of Long-Acting Injectable Buprenorphine at Substance Use Treatment Facilities in 2021. JAMA. 2024 02 13; 331(6):524-526.
-
Predictive Factors Associated with Naloxone Prescription among Pregnant People Admitted for the Management of Opioid Use Disorder. Am J Perinatol. 2024 04; 41(5):539-542.
-
Medical Student Screening for Naloxone Eligibility in the Emergency Department: A Value-Added Role to Fight the Opioid Epidemic. MedEdPORTAL. 2021; 17:11196.
-
Use of Anticraving Agents in the Treatment of Exhibitionism and Frotteuristic Disorder. J Clin Psychopharmacol. 2021 Sep-Oct 01; 41(5):611-612.
-
Point-of-care naloxone distribution in the emergency department: A pilot study. Am J Health Syst Pharm. 2021 02 08; 78(4):360-366.
-
Modeling Mitigation Strategies to Reduce Opioid-Related Morbidity and Mortality in the US. JAMA Netw Open. 2020 11 02; 3(11):e2023677.
-
Take-Home Naloxone Program Implementation: Lessons Learned From Seven Chicago-Area Hospitals. Ann Emerg Med. 2020 09; 76(3):318-327.
-
Medical Management of Opioid-Induced Constipation. JAMA. 2019 12 10; 322(22):2241-2242.